Profile
Carmen Herrero is the founder of Kintsugi Therapeutics.
She held the titles of Chief Executive Officer and Director at the company.
Carmen Herrero active positions
| Companies | Position | Start |
|---|---|---|
Kintsugi Therapeutics
 Kintsugi Therapeutics Pharmaceuticals: MajorHealth Technology Kintsugi Therapeutics is a biomedical start-up based in Barcelona, Spain. The Spanish company focuses on developing innovative therapies for the treatment of liver conditions and other pathologies by targeting the regulation of endoplasmic reticulum stress. The company's lead candidate is a first-in-class endoplasmic reticulum stress inhibitor being developed for the treatment of non-alcoholic steatohepatitis (NASH). The company was founded by Carmen Herrero and Marc Cusachs, with Carmen Herrero serving as the CEO since incorporation. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Kintsugi Therapeutics
Kintsugi Therapeutics Pharmaceuticals: MajorHealth Technology Kintsugi Therapeutics is a biomedical start-up based in Barcelona, Spain. The Spanish company focuses on developing innovative therapies for the treatment of liver conditions and other pathologies by targeting the regulation of endoplasmic reticulum stress. The company's lead candidate is a first-in-class endoplasmic reticulum stress inhibitor being developed for the treatment of non-alcoholic steatohepatitis (NASH). The company was founded by Carmen Herrero and Marc Cusachs, with Carmen Herrero serving as the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Carmen Herrero
